Cardiothoracic & vascular anesthesia

Multivariable Predictive Model of Postoperative Delirium in Cardiac Surgery Patients: Proteomic and Demographic Contributions

Anesth AnalgPublished Prognostic biomarker study

Authors' conclusion

Our results support the identification of patients at higher risk of developing delirium after cardiac surgery using a multivariable model that combines demographic and physiological features, also bringing light to the role of immune and vascular dysregulation as underlying mechanisms.

Study context

Population
Older adults undergoing cardiac surgery requiring CPBvalidation
Participants
115 adults
Comparison
Delirious vs nondelirious patients
  • Deliriumn = 21
Outcome
Postoperative delirium
Methodological detailsproteomic screening (SomaScan), validation cohort (Enzyme-Linked Lectin Assay (ELLA) multiplex immunoassay), multivariable predictive model
  • Proteomic screening (SomaScan)
  • Validation cohort (ELLA multiplex immunoassay)
  • Multivariable predictive model

Performance

As reported in the abstract

Best performing predictive model for delirium (age, sex, angiopoietin-2, C-C motif chemokine 5, metalloproteinase inhibitor 1)

Delirium incidence

18.3%

Model AUC

0.829

Further findings

Differentially expressed proteins, delirious vs nondelirious (SomaScan screening) · preoperatively and POD2

Proteins differentially expressed preoperatively
115
Proteins differentially expressed at POD2
85
  • P < .05

Biomarker candidates selected for ELLA validation

Candidates (|tFC| >1.4, BH-P < .01)
12

Pathway analysis

Delirium-associated proteins involved in inflammation, glial dysfunction, vascularization, and hemostasis

Original publication

Multivariable Predictive Model of Postoperative Delirium in Cardiac Surgery Patients: Proteomic and Demographic Contributions. Anesth Analg. Published 10 January 2025. doi:10.1213/ane.0000000000007293

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.